Asociación Civil Selva Amazónica Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01314937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Asociacion Civil Selva Amazonica | Asociación Civil Selva Amazónica (ACSA)

Active Ingredients

Drugs in Phase 4 Trials (2)

albendazole (Albenza) (1 trial)

mebendazole (vermox) (1 trial)

Drugs in Phase 2 Trials (2)

dsm265 (1 trial)

(+)-sj000557733 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intestinal Diseases (Phase 4)

Intestinal Diseases, Parasitic (Phase 4)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Malaria, Vivax (Phase 2)

Malnutrition (Phase 4)

Parasitic Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4